• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday

    3/13/24 10:22:00 AM ET
    $ADCT
    $ARCO
    $CMTL
    $DLTR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Restaurants
    Consumer Discretionary
    Get the next $ADCT alert in real time by email

    U.S. stocks were mixed, with the Dow Jones index surging more than 100 points on Wednesday.

    Shares of Dollar Tree, Inc. (NASDAQ:DLTR) fell sharply during Wednesday’s session after the company reported worse-than-expected fourth-quarter financial results and issued first-quarter EPS guidance below estimates.

    Dollar Tree reported fourth-quarter FY23 sales growth of 11.9% year-on-year to $8.63 billion, missing the analyst consensus estimate of $8.67 billion. Adjusted EPS of $2.55 missed the consensus estimate of $2.65, according to data from Benzinga Pro.

    Dollar Tree shares dipped 14.5% to $128.00 on Wednesday.

    Here are some other big stocks recording losses in today’s session.

    • NaaS Technology Inc. (NASDAQ:NAAS) declined 20.1% to $1.19 after the company announced a $6 million registered direct offering.
    • Comtech Telecommunications Corp. (NASDAQ:CMTL) dipped 19% to $4.6599. Comtech named John Ratigan as Interim Chief Executive Officer.
    • loanDepot, Inc. (NYSE:LDI) dipped 15.9% to $2.1350 following weak quarterly results.
    • Rackspace Technology, Inc. (NASDAQ:RXT) tumbled 13.3% to $1.9150 after the company issued first-quarter guidance below estimates. The company also announced refinancing transactions.
    • ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) dipped 12.4% to $10.22 following weak quarterly sales.
    • Neumora Therapeutics, Inc. (NASDAQ:NMRA) fell 12.2% to $15.24.
    • Tevogen Bio Holdings Inc. (NASDAQ:TVGN) dipped 8.8% to $6.09.
    • ADC Therapeutics SA (NASDAQ:ADCT) fell 8.8% to $4.06 following quarterly results.
    • Solowin Holdings (NASDAQ:SWIN) declined 8.6% to $26.61.
    • Arcos Dorados Holdings Inc. (NYSE:ARCO) dipped 8.4% to $10.95 following downbeat quarterly earnings.
    • Ichor Holdings, Ltd. (NASDAQ:ICHR) fell 8% to $39.27 after announcing a $125 million public offering of ordinary shares.
    • Nukkleus Inc. (NASDAQ:NUKK) fell 5.4% to $1.06.
    • Tesla, Inc. (NASDAQ:TSLA) shares declined 2.4% to $173.22 after Wells Fargo downgraded the stock from Equal-Weight to Underweight and lowered its price target from $200 to $125.

     

    Now Read This: NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday

    Get the next $ADCT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADCT
    $ARCO
    $CMTL
    $DLTR

    CompanyDatePrice TargetRatingAnalyst
    Tevogen Bio Holdings Inc.
    $TVGN
    3/4/2026Buy → Hold
    D. Boral Capital
    Tesla Inc.
    $TSLA
    3/4/2026$460.00Buy
    BofA Securities
    Dollar Tree Inc.
    $DLTR
    2/27/2026$132.00Buy → Neutral
    Citigroup
    Dollar Tree Inc.
    $DLTR
    2/17/2026$165.00Neutral → Buy
    Rothschild & Co Redburn
    Neumora Therapeutics Inc.
    $NMRA
    2/17/2026Mkt Perform → Outperform
    William Blair
    Dollar Tree Inc.
    $DLTR
    2/13/2026$95.00Market Perform → Underperform
    BMO Capital Markets
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    Ichor Holdings
    $ICHR
    2/10/2026$52.00Neutral → Buy
    B. Riley Securities
    More analyst ratings

    $ADCT
    $ARCO
    $CMTL
    $DLTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tevogen Bio downgraded by D. Boral Capital

    D. Boral Capital downgraded Tevogen Bio from Buy to Hold

    3/4/26 9:36:27 AM ET
    $TVGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BofA Securities resumed coverage on Tesla with a new price target

    BofA Securities resumed coverage of Tesla with a rating of Buy and set a new price target of $460.00

    3/4/26 8:40:18 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Dollar Tree downgraded by Citigroup with a new price target

    Citigroup downgraded Dollar Tree from Buy to Neutral and set a new price target of $132.00

    2/27/26 8:27:18 AM ET
    $DLTR
    Department/Specialty Retail Stores
    Consumer Discretionary

    $ADCT
    $ARCO
    $CMTL
    $DLTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Arcos Dorados to Host Its 2026 Annual General Shareholders' Meeting

    Arcos Dorados Holdings Inc. (NYSE:ARCO) ("Arcos Dorados" or the "Company"), Latin America's largest restaurant chain and the world's largest independent McDonald's franchisee, today announced that on March 6, 2026, its Board of Directors set the date for the Company's Annual Shareholders' Meeting ("AGM"). The AGM will be held on April 10, 2026, in Montevideo, Uruguay, at 2:00 p.m. (local time), for all shareholders of record as of March 16, 2026. Follow us on: LinkedIn, Instagram, X, and YouTube About Arcos Dorados Arcos Dorados is the world's largest independent McDonald's franchisee, operating the largest quick service restaurant chain in Latin America and the Caribbean. It has the

    3/6/26 5:00:00 PM ET
    $ARCO
    Restaurants
    Consumer Discretionary

    Letter to Shareholders from CEO Dr. Ryan Saadi

    WARREN, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN). Dear Shareholders, As we continue executing on Tevogen's long-term strategy to evolve into a sustainable, revenue-generating healthcare enterprise, I would like to provide an update regarding our ongoing strategic initiatives. Over the past several months, we have been actively evaluating potential acquisitions designed to complement our existing immunotherapy and artificial intelligence platforms. If consummated, these transactions are expected to operate as subsidiaries of Tevogen resulting in positive cash flow generation and a return on invested capital over time. Base

    3/6/26 3:40:00 PM ET
    $TVGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical

    WARREN, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent ("LoI") to evaluate a potential transaction with Apozeal Pharmaceutical Inc. ("Apozeal"), a pharmaceutical company focused on the development and manufacturing of high-quality, cost-effective medicines. The proposed transaction represents a strategic step in advancing Tevogen Generics, established to support domestic pharmaceutical manufacturing and enhance affordability and national supply chain resilience. If consummated, the potential acquisition of Apozeal could provide Tevogen

    3/5/26 2:50:00 PM ET
    $TVGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADCT
    $ARCO
    $CMTL
    $DLTR
    SEC Filings

    View All

    SEC Form 144 filed by Tesla Inc.

    144 - Tesla, Inc. (0001318605) (Subject)

    3/6/26 5:42:03 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    SEC Form 6-K filed by Arcos Dorados Holdings Inc.

    6-K - Arcos Dorados Holdings Inc. (0001508478) (Filer)

    3/6/26 5:06:45 PM ET
    $ARCO
    Restaurants
    Consumer Discretionary

    SEC Form 6-K filed by NaaS Technology Inc.

    6-K - NaaS Technology Inc. (0001712178) (Filer)

    3/6/26 4:30:18 PM ET
    $NAAS
    Other Specialty Stores
    Consumer Discretionary

    $ADCT
    $ARCO
    $CMTL
    $DLTR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 18, 2024 - FDA Roundup: June 18, 2024

    For Immediate Release: June 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a request for input about patient safety associated with certain medical software functions excluded from the medical device definition. This input will help the FDA develop the 2024 report on the risks and benefits to health of non-devic

    6/18/24 3:16:28 PM ET
    $DLTR
    $AMGN
    Department/Specialty Retail Stores
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-5) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:04:01 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-4) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:03:14 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $ARCO
    $CMTL
    $DLTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Patenaude Pamela H. converted options into 24,606 shares, increasing direct ownership by 8% to 318,293 units (SEC Form 4)

    4 - loanDepot, Inc. (0001831631) (Issuer)

    3/3/26 4:35:25 PM ET
    $LDI
    Finance: Consumer Services
    Finance

    Director Lepore Dawn G converted options into 24,606 shares, increasing direct ownership by 13% to 208,351 units (SEC Form 4)

    4 - loanDepot, Inc. (0001831631) (Issuer)

    3/3/26 4:39:20 PM ET
    $LDI
    Finance: Consumer Services
    Finance

    Director Ozonian Steven converted options into 24,606 shares, increasing direct ownership by 15% to 192,889 units (SEC Form 4)

    4 - loanDepot, Inc. (0001831631) (Issuer)

    3/3/26 4:40:20 PM ET
    $LDI
    Finance: Consumer Services
    Finance

    $ADCT
    $ARCO
    $CMTL
    $DLTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Sc Capital Ii Sponsor Llc bought $2,550,000 worth of Class A ordinary shares (255,000 units at $10.00) (SEC Form 4)

    4 - Nukkleus Inc. (0001787518) (Reporting)

    12/1/25 5:20:47 PM ET
    $NUKK
    Professional Services
    Consumer Discretionary

    Director Mackenzie Iain bought $145,300 worth of Ordinary Shares (10,000 units at $14.53), increasing direct ownership by 8% to 130,011 units (SEC Form 4)

    4 - ICHOR HOLDINGS, LTD. (0001652535) (Issuer)

    11/17/25 6:23:54 PM ET
    $ICHR
    Semiconductors
    Technology

    Director Mackenzie Iain bought $152,800 worth of Ordinary Shares (10,000 units at $15.28), increasing direct ownership by 9% to 120,011 units (SEC Form 4)

    4 - ICHOR HOLDINGS, LTD. (0001652535) (Issuer)

    11/10/25 4:09:17 PM ET
    $ICHR
    Semiconductors
    Technology

    $ADCT
    $ARCO
    $CMTL
    $DLTR
    Financials

    Live finance-specific insights

    View All

    ZIM to Release Fourth Quarter and Full Year 2025 Results on Monday, March 9, 2026

    HAIFA, Israel, March 3, 2026 /PRNewswire/ -- ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) announced today that the Company will release its fourth quarter and full year 2025 financial results on Monday, March 9, 2026, before the U.S. financial markets open.   In light of the pending merger transaction with Hapag-Lloyd announced by the Company on February 17, 2026, the Company will not be holding a conference call or providing financial guidance.About ZIMFounded in Israel in 1945, ZIM (NYSE:ZIM) is a leading global container liner shipping company with established operations in more than 90 countries serving approximately 33,000 customers in over 300 ports worldwide. ZIM leverages digital

    3/3/26 8:00:00 AM ET
    $ZIM
    Marine Transportation
    Consumer Discretionary

    ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026

    LAUSANNE, Switzerland, March 3, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE:ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it will host a conference call and live webcast on Tuesday, March 10, 2026, at 8:30 a.m. EDT to report financial results for the fourth quarter and full year ended December 31, 2025, and provide operational updates. To access the conference call, please register here. The participant toll-free dial-in number is 1-800-836-8184 for North America and Canada. It is recommended that you

    3/3/26 7:15:00 AM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rackspace Technology Reports Fourth Quarter and Full Year 2025 Results

    Fourth Quarter Revenue of $683 million, down 0.4% Year-over-Year; 2025 Revenue of $2,686 million, down 2% Year-over-YearFourth Quarter Private Cloud Revenue of $241 million, down 10% Year-over-Year; 2025 Private Cloud Revenue of $990 million, down 6% Year-over-YearFourth Quarter Public Cloud Revenue of $442 million, up 6% Year-over-Year; 2025 Public Cloud Revenue of $1,696 million up 1% Year-over-YearFourth Quarter Cash Flow From Operating Activities of $60 million; 2025 Cash Flow From Operating Activities of $151 million SAN ANTONIO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology, Inc. (NASDAQ:RXT), a leading end-to-end hybrid cloud and AI solutions company, today announc

    2/26/26 8:00:00 AM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    $ADCT
    $ARCO
    $CMTL
    $DLTR
    Leadership Updates

    Live Leadership Updates

    View All

    Arcos Dorados Holdings Inc. Fourth Quarter 2025 Results Webcast Date and Time

    Scheduled for: Thursday, March 19, 2026 10:00 a.m. New York / 11:00 a.m. Montevideo Arcos Dorados Holdings Inc. (NYSE:ARCO) will hold a webcast to discuss its results for the fourth quarter and full year ended December 31, 2025, which will be released before the market opens on Thursday, March 19, 2026. Luis Raganato, Chief Executive Officer, and senior management will host the webcast. Opening remarks will be followed by a question-and-answer period. Participants from the investment community will be able to join the webcast (Google Chrome is recommended) using the following link: Arcos Dorados Fourth Quarter 2025 Earnings Webcast. The link will also be available on the Events section

    2/19/26 7:15:00 AM ET
    $ARCO
    Restaurants
    Consumer Discretionary

    Joseph Vito Joins Rackspace Technology to Lead Strategic Alliance Partnerships

    SAN ANTONIO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ:RXT), a leading end-to-end hybrid cloud and AI solutions company, today announced the appointment of Joseph Vito as Senior Vice President of Strategic Alliance Partnerships. In this role, Vito will lead Rackspace's global strategy for building and strengthening technology and channel partnerships that drive innovation and deliver exceptional value to customers. Vito brings more than 25 years of experience in technology leadership, cloud transformation, and enterprise solutions across financial services, life sciences, energy, and consumer manufacturing. Most recently, he served as a Strategic Transformation Princ

    1/27/26 8:15:00 AM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    Dollar Tree Appoints Daniel Delrosario as Senior Vice President of Investor Relations and Treasurer

    Dollar Tree, Inc. (NASDAQ:DLTR) today announced that Daniel Delrosario has been named Senior Vice President of Investor Relations and Treasurer, effective today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112636253/en/Dollar Tree Appoints Daniel Delrosario as Senior Vice President of Investor Relations and Treasurer In this role, Mr. Delrosario will serve as a senior leader in the company's finance organization, overseeing investor relations and treasury, including capital markets strategy, liquidity management, and engagement with the investment community. He will report to Stewart Glendinning, Chief Financial Officer of

    1/13/26 7:00:00 AM ET
    $DLTR
    Department/Specialty Retail Stores
    Consumer Discretionary

    $ADCT
    $ARCO
    $CMTL
    $DLTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by loanDepot Inc.

    SC 13D/A - loanDepot, Inc. (0001831631) (Subject)

    12/5/24 7:00:55 PM ET
    $LDI
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by loanDepot Inc.

    SC 13D/A - loanDepot, Inc. (0001831631) (Subject)

    11/25/24 9:34:43 PM ET
    $LDI
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by Neumora Therapeutics Inc.

    SC 13D/A - Neumora Therapeutics, Inc. (0001885522) (Subject)

    11/22/24 5:33:43 PM ET
    $NMRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care